In two groups of patients undergoing induced hypotension with sodium nitroprusside or trimetaphan blood concentrations of lactate, pyruvate and standard bicarbonate did not differ significantly between the groups. In the nine patients who received trimetaphan there was a progressive, but statistically non-significant, decrease in mean lactate. Nitroprusside (15 patients) was associated with a small increase in mean lactate, but at low dosage there was a small decrease. No relationship to dose rate of nitroprusside was found with these short-term infusions. It is concluded that sodium nitroprusside can be used safely for induced hypotension at doses less than 1.5 mg kg" 1 and that simple blood-gas analysis is adequate for the assessment of toxic effects when greater doses are given.
Since its introduction for inducing hypotension during anaesthesia (Jones and Cole, 1968 ) sodium nitroprusside has become widely used because its brief duration of action allows accurate control of hypotension and rapid restoration of arterial pressure at the end of the procedure, although there has always been concern about toxicity because metabolism of sodium nitroprusside results in formation of cyanide. Vesey, Cole and Simpson (1976) , having reviewed case reports of presumed cyanide poisoning after nitroprusside and having measured cyanide concentrations in plasma and red blood cells during and after its infusion in man, made recommendations regarding the safe maximum dose. However, cyanide measurements have been questioned as suitable indicators of exposure to cyanide after nitroprusside (Smith and Kruszyna, 1976) .
Cyanide blocks oxidative phosphorylation by the cytochromes. Some energy is produced anaerobically by glycolysis with production of lactate when pyruvate cannot enter the Kreb's cycle. We have studied blood lactate and pyruvate concentrations as indicators of this effect of cyanide release in patients receiving nitroprusside to induce hypotension during anaesthesia. Patients who received trimetaphan were studied as controls. studied. The nature of the study was explained to the patient and consent obtained. Premedication was with oral diazepam 10 mg. Anaesthesia was induced with thiopentone 250-400 mg and endotracheal intubation performed with the aid of pancuronium 6-8 mg. Anaesthesia was maintained with 50% nitrous oxide in oxygen with halothane 1-2%. The lungs were ventilated artificially at 15 b.p.m. using a Cape-Waine anaesthetic ventilator (Cape Engineering Ltd) with tidal volume set so that expired volume, measured with a Wright respirometer (British Oxygen Company Ltd), equalled that indicated by the Radford (1955) nomogram.
After induction of anaesthesia a 19-gauge Venflon cannula (Everett Medical Products Ltd) was inserted percutaneously into a radial artery to allow measurement of arterial pressure and sampling of arterial blood. After 15 min of stable anaesthesia samples of arterial blood were collected for estimation of lactate, pyruvate and haemoglobin concentrations and for blood-gas analysis. An infusion of 0.9% saline containing either sodium nitroprusside (prepared by the hospital pharmacy) or trimetaphan (Arfonad, Roche) was started. Allocation to either drug was on a random basis and infusion rates were adjusted to produce a systolic arterial pressure of 60 mm Hg. The infusion was continued until the end of surgery, when a second set of samples was taken. Pancuronium was antagonized with neostigmine, the tracheal tube removed, and the patient breathed 35% oxygen from a Ventimask (Vickers Medical Ltd) until a third set of samples was taken 1 h after the second. The arterial cannula was then removed.
Blood samples for lactate and pyruvate and bloodgas estimation were drawn into two heparinized iced glass syringes. One was sealed and placed in an icewater mixture for transport to the laboratory where analyses for H+, Pa Os and Pa c02 were performed using an IL 213 microelectrode system. Standard bicarbonate was derived from H+ and Pa C02 using the Siggaard-Andersen alignment nomogram. The lactate-pyruvate sample was immediately decanted into an iced glass tube. An aliquot was aspirated to an iced glass pipette, placed in an equal volume of iced perchloric acid, the mixture centrifuged, and the supernatant liquid assayed for lactate and pyruvate using an enzymatic method (The Boehringer Corporation (London) Ltd).
Following the comparative study another six patients who received nitroprusside were studied to provide more data for analysis of the dose-effect relationship on lactate-pyruvate changes.
Differences between the two randomized groups were compared using a t test for two means, and changes within groups compared with a paired t test. Table I shows the details of the two groups of patients in the comparative study. Those who received trimetaphan were younger, heavier and underwent procedures of shorter duration than those who received nitroprusside, but none of the differences was statistically significant. The results from one patient in each group were incomplete and have been omitted. Table II summarizes the blood-gas data. The patients in both groups were well oxygenated and there were minimal changes in mean Pa C02 . study. Changes in the measurements were generally small and inconsistent. There was a small progressive decrease in mean lactate concentration in those who received trimetaphan whereas there was a small increase in the nitroprusside group between the second and third samples. In none of these measurements were within-group changes or between-group differences statistically significant. Table III also summarizes the data for the additional six patients studied with nitroprusside infusion. Changes in lactate concentration in all 15 patients receiving nitroprusside were analysed in respect of both total dose and dose rate and no obvious relationships were apparent; neither were changes in lactate concentration related to duration of hypotension.
RESULTS
Lactate concentration decreased in the majority of patients ( fig. 1 ) and the slight increase in mean lactate concentration in the original nitroprusside group was caused almost entirely by one patient whose arterial pressure was resistant to the effect of nitroprusside from the outset. The results for this patient are shown in table IV, with some subsequent blood-gas values and vitamin B 12 concentrations: the lactate concentration increased and there was a decrease in standard bicarbonate; the lactate/pyruvate ratio decreased and the excess lactate value (Huckabee, 1958) was negative. At the end of the procedure the patient's condition was clinically un- 
DISCUSSION
Certain physiological and other safeguards are necessary to allow blood lactate concentrations to be used to assess intracellular acidosis. Although it is an indirect method it is the best available (Cohen and Simpson, 1975) . Oxygen delivery to the tissues must be adequate: the patients in the present study were all well oxygenated and cardiac output is known to be normal or slightly increased during induced hypotension with nitroprusside (Wildsmith et al., 1973) . Changes in Pco 2 , particularly hypocapnia, affect lactate concentration (Cohen and Woods, 1976) and for that reason we maintained normocapnia. Infusion of glucose can increase blood lactate (Cohen and Woods, 1976) ; we gave the drugs in saline. Blood was withdrawn from an arterial cannula to avoid stasis. All glassware was iced and the specimen for lactate decanted into perchloric acid as soon as possible so that the effect of red cell glycolysis after withdrawal was minimal. Lactate and pyruvate data are often expressed as the ratio of the two, but we do not believe this to be valuable. In the one patient with clear changes, this ratio decreased when it would have been expected to increase. This was because there was a greater proportional increase in pyruvate than in lactate. Excess lactate has also been used to indicate changes in lactate concentration independent of alterations in pyruvate (Huckabee, 1958) . Mathematically, however, this figure is not independent of pyruvate (Cohen and Woods, 1976) and in one patient the change was the reverse of that which would be expected.
The results show that hypotensive anaesthesia with trimetaphan is not associated with any evidence of (Chamberlain and Lis, 1968; Yamazaki et al., 1975) . Sodium nitroprusside in low doses also decreased lactate concentrations and it has been used (Taradosh and Jacobsen, 1973) to treat idiopathic lactic acidosis associated with poor peripheral perfusion.
With larger doses, the lactate concentration may increase, presumably as the toxic effect begins to counter the effect on perfusion. The patient who showed resistance to the hypotensive effect of sodium nitroprusside required 1.6 mg kg" 1 and had the greatest increase in lactate concentration ( fig. 1) . Although the increase was small and recovery uneventful, this case shows the need to limit total dosage in acute administration, and these results would support the suggested maximum dose of 1.5 mg kg -1 based on cyanide studies (Vesey, Cole and Simpson, 1976) . Suggestions have also been made regarding the maximum safe dose rate (Editorial, 1978 )-a dose of 10 (ig kg" 1 min" 1 being quoted. While this may apply to administration over a period of days, our results indicate little relationship to dose rate during hypotensive anaesthesia.
The increase in blood lactate concentration in the resistant patient could have been caused by a reduction in hepatic clearance because of a reduction in liver blood flow, rather than by increased production of lactate. Little is known about liver blood flow during administration of nitroprusside, but clearance of indocyanine green has been used as an indicator of this and is not influenced by infusion of nitroprusside during halothane anaesthesia (Abdel Salam et al., 1976) .
This study investigated the effects of clinical use of sodium nitroprusside on metabolism. Instead of measuring cyanide concentrations, and attempting to deduce toxicity indirectly, we looked for alteration in the metabolic state. When it is used within its known toxic concentrations, there is no significant metabolic upset. This means that for practical purposes the drug can be administered in normal doses without fear of producing metabolic acidosis, except in patients with known contraindications (Cole, 1978) .
Unfortunately, this does not mean that the problem of metabolic acidosis as a potential complication can be ignored. There is no means of predicting how much drug will be needed for any particular patient. Most require only small amounts, but occasionally doses approaching 1.5 mg kg" 1 are needed. It has been argued that safe use of nitroprusside requires ready access to lactate estimation (Editorial, 1978) , but our results confirm animal studies which suggested that changes in lactate are mirrored by changes in bicarbonate concentration (Simpson et al., 1977) . Blood-gas analysis is easier, quicker and cheaper to perform and far more readily available. We would consider that this estimation is adequate for assessing toxicity following acute administration during anaesthesia, and make it when the total dose is likely to exceed 1.5 mg kg" 1 . 
RESUME

SUMARIO
En dos grupos de pacientes sometidos a hipotension inducida mediante nitroprusiato de sodio o trimetafan, no difirieron de manera significativa entre los grupos las concentraciones de lactato en la sangre y las concentraciones de piruvato y de bicarbonato normal. En los nueve pacientes a quienes fue administrado trimetafan, hubo una reducci6n progresiva de lactato medio, aunque no-significativa desde el punto de vista estadistico. Se hall6 (15 pacientes) nitroprusiato asociado con un ligero aumento de lactato medio, pero en dosajes bajos, se registr6 una pequena reduccion. No se encontr6 ninguna relacion con el porcentaje de las dosis de nitroprusiato en estas infusiones de com duration. Se concluye que puede usarse en toda seguridad el nitroprusiato de sodio para hipotension inducida en dosis menores de 1,5 mg kg-1 y que es adecuado un simple analisis sangre-gas para evaluar los efectos t6xicos cuando se administren dosis mayores.
